- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
NuPathe Inc+ Add to Watchlist
PATH:US3.1700 USD 0.0600 1.93%
As of 20:10:00 ET on 05/24/2013.
Company Profile for NuPathe Inc (PATH)
NuPathe Inc. develops pharmaceutical products used for the treatment and management of neurological and psychiatric diseases. The Company offers various medicines for migraines, Parkinson's, schizophrenia, and other cognitive disorders.
Key Executives for NuPathe Inc (PATH)
|Wayne P YetterChairman||Armando AnidoChief Executive Officer|
|Terri B SebreePresident/Co-Founder||Keith Alan GoldanVP/CFO|
|Gerald W McLaughlin "Jerry"VP/Chief Commercial Officer||Michael F MarinoVP/Secretary/General Counsel|